MetLife Investment Management’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,081	Closed	-$64.5K	–	2939
2023 Q1	$64.5K	Buy	+5,081	New	+$64.5K	﹤0.01%	2686